Randomized Comparison of Selective Internal Radiotherapy (SIRT) Versus Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) for the Treatment of Hepatocellular Carcinoma

@inproceedings{Pitton2014RandomizedCO,
  title={Randomized Comparison of Selective Internal Radiotherapy (SIRT) Versus Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) for the Treatment of Hepatocellular Carcinoma},
  author={Michael B. Pitton and Roman Kloeckner and Christian Ruckes and Gesine Maria Wirth and Waltraud Eichhorn and Marcus Alexander Woerns and Arndt Weinmann and Mathias Schreckenberger and Peter R. Galle and G. F. Otto and Christoph D{\"u}ber},
  booktitle={CardioVascular and Interventional Radiology},
  year={2014}
}
To prospectively compare SIRT and DEB-TACE for treating hepatocellular carcinoma (HCC). From 04/2010–07/2012, 24 patients with histologically proven unresectable N0, M0 HCCs were randomized 1:1 to receive SIRT or DEB-TACE. SIRT could be repeated once in case of recurrence; while, TACE was repeated every 6 weeks until no viable tumor tissue was detected by MRI or contraindications prohibited further treatment. Patients were followed-up by MRI every 3 months; the final evaluation was 05/2013… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS